Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population
Clinical Obesity · 2024
DOI: 10.1111/cob.12649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Obesity, 2024. Verfasst von Laurence J Dobbie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Liraglutide, Prediabetic State, Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
UK guidelines recommend liraglutide 3.0 mg in adults treated within specialist weight management services with BMI ≥35 kg/m 2 , prediabetes and high cardiovascular disease risk. We aimed to clinically evaluate liraglutide 3.0 mg in specialist weight management services. We evaluated liraglutide 3.0 mg in weight management services at Guys and St Thomas' NHS Foundation Trust. Objective body weight (BW) was measured at baseline and 4 months, allowing classification as ‘responders’ (≥5% BW reduction) and ‘non‐responders’ (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Nutrition and Dietetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
ORCID-Profile: Laurence J Dobbie, Barbara McGowan
Zitieren
APA
Dobbie, L. J., Coelho, C., Mgaieth, F., Chauhan, K., Campbell, S., Shuriye, S., Hollington, J., Appleton, S., Sen Gupta, P., Duncan, A., & McGowan, B. (2024). Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population. Clinical Obesity. https://doi.org/10.1111/cob.12649
Vancouver
Dobbie LJ, Coelho C, Mgaieth F, Chauhan K, Campbell S, Shuriye S, et al. Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population. Clinical Obesity. 2024. doi:10.1111/cob.12649
BibTeX
@article{Dobbie2024,
author = {Dobbie, Laurence J and Coelho, Claudia and Mgaieth, Farah and Chauhan, Keisha and Campbell, Scott and Shuriye, Sumaya and Hollington, Joanna and Appleton, Sarah and Sen Gupta, Piya and Duncan, Alastair and McGowan, Barbara},
title = {Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population},
journal = {Clinical Obesity},
year = {2024},
doi = {10.1111/cob.12649}
}
EUVIMED